Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIQ-AI Regulatory News (IQAI)

  • There is currently no data for IQAI

KFDA Clearance for StoneChecker Software

20 Jan 2020 07:00

RNS Number : 2389A
IQ-AI Limited
20 January 2020
 

IQ-AI Ltd

("IQ-AI" or the "Company")

 

IQ-AI Announce Korean FDA Clearance to Market for StoneChecker Software, and GMP certification for Imaging Biometrics, and the appointment of Dr Balaji Ganeshan as consultant

 

IQ-AI has received notification that the Korean FDA (KFDA) has cleared StoneChecker Software for marketing in the Republic of Korea, a key market for high-tech medical imaging hardware and software. In addition, Imaging Biometrics (IB) has received GMP certification.

 

Trevor Brown, Chief Executive of IQ-AI commented, "We are delighted that StoneChecker Software has received KFDA approval for marketing in the Republic of Korea, our Korean distributor's marketing plans can now be fully implemented. It also gives me great pleasure to welcome back Dr Balaji Ganeshan to the team. Dr Ganeshan, an exceptionally innovative medical imaging entrepreneur and scientist, has invaluable expertise and ideas in a number of key technologies relevant to the Company. He will be working as a consultant for IB."

 

Dr Ganeshan, who was previously a director of StoneChecker Software, holds the position of Senior Research Associate at the Institute of Nuclear Medicine at University College London and is a prolific academic scientist in the area of medical image analysis. 

 

Dr. Balaji Ganeshan commented, "I very much look forward to working alongside Trevor Brown again, and also the team at IB, on all the technologies that IQ-AI have access to."

 

The Directors of the Company accept responsibility for the contents of this announcement.

 

-ENDS-

 

For further information, please contact:

IQ-AI Limited

Trevor Brown/Michael Schmainda

Tel: 020 7469 0930

Peterhouse Capital Limited (Financial Adviser and Broker)

Lucy Williams/Heena Karani

Tel: 020 7220 9797

 

About IQ-AI Ltd 

IQ-AI, Ltd, the parent company of StoneChecker® and Imaging Biometrics®, is focused on advanced and state of the art medical software and services. Imaging Biometrics develops and provides visualization and analytical solutions that enable clinicians to better diagnose and treat diseases with greater confidence. Through close collaboration with researchers and clinicians, sophisticated advancements are translated into platform-independent software plug-ins which can extend the base functionality of workstations, imaging systems, PACS, or medical viewers. By design, IB's advanced visualization software seamlessly integrates into routine workflows. Please visit www.imagingbiometrics.com for further information.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
STRSFFFAUESSEEF
Date   Source Headline
26th Aug 20089:53 amRNSEPT Disclosure
22nd Aug 20089:16 amRNSEPT Disclosure
22nd Aug 20088:31 amRNSEPT Disclosure
21st Aug 20088:42 amRNSEPT Disclosure
20th Aug 20089:02 amRNSEPT Disclosure
19th Aug 20089:11 amRNSEPT Disclosure
18th Aug 200810:42 amRNSEPT Disclosure
18th Aug 20089:52 amRNSEPT Disclosure
14th Aug 20089:25 amRNSEPT Disclosure
13th Aug 20082:53 pmPRNRule 8.3 - Flying Brands
13th Aug 200810:17 amBUSRule 8.3 - Flying Brands
13th Aug 20089:06 amRNSEPT Disclosure
12th Aug 20089:22 amBUSRule 8.3 - Flying Brands
12th Aug 20088:34 amRNSEPT Disclosure
12th Aug 20088:23 amRNSEPT Disclosure
11th Aug 20081:24 pmPRNRule 8.3 - Flying Brands Limited
11th Aug 200811:00 amRNSEPT Disclosure
11th Aug 200810:23 amBUSRule 8.3 - Flying Brands
11th Aug 20088:58 amRNSEPT Disclosure
8th Aug 200810:17 amRNSEPT Disclosure
8th Aug 20089:48 amRNSEPT Disclosure
7th Aug 20083:42 pmRNSStatement re Possible Offer
1st Aug 20087:00 amRNSInterim Results
3rd Jul 20086:23 pmRNSTrading Statement
4th Jun 20085:35 pmRNSHolding(s) in Company
2nd Jun 20089:59 amRNSCEO Appointment
29th May 20083:30 pmRNSTrading Statement
8th May 20085:01 pmRNSAnnual Information Update
8th May 20084:27 pmRNSBlocklisting Interim Review
8th May 20084:26 pmRNSAnnual Report and Accounts
23rd Apr 200810:19 amRNSAGM Statement
14th Mar 20087:01 amRNSFinal Results
29th Feb 20087:01 amRNSNotice of Final Results
17th Jan 20081:39 pmRNSTrading Statement
13th Nov 20075:59 pmRNSHolding(s) in Company
23rd Oct 20077:02 amRNSTrading Update
27th Sep 200711:18 amRNSTotal Voting Rights
26th Sep 200711:00 amRNSBlocklisting Interim Review
6th Sep 20073:27 pmRNSDirectorate Change
27th Jul 20077:01 amRNSInterim Results
9th Jul 20077:00 amRNSNotice of Interim Results
6th Jul 200710:50 amRNSHolding(s) in Company
1st Jun 20078:00 amRNSHolding(s) in Company
8th May 20072:29 pmRNSDirector/PDMR Shareholding
25th Apr 200710:10 amRNSHolding(s) in Company
17th Apr 200710:44 amRNSAGM Statement & Board Changes
27th Mar 20072:40 pmRNSBlocklisting Interim Review
20th Mar 20079:01 amRNSHolding(s) in Company
16th Mar 20077:01 amRNSFinal Results
26th Feb 20077:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.